<DOC>
	<DOCNO>NCT00606723</DOCNO>
	<brief_summary>1 . To evaluate whether stem cell transplantation match sibling donor equivalent match unrelated donor second complete remission acute myeloid leukemia ( AML ) . 2 . To evaluate whether stem cell transplantation ( SCT ) chemotherapy ( FLAMSA-schema ) increase survival compare threshold derive historical data 3 . To evaluate whether SCT haploidentical donor child match donor result well survival acceptable toxicity .</brief_summary>
	<brief_title>Allogenic Stem Cell Transplantation Children , Adolescents Young Adults With Relapsed Refractory AML</brief_title>
	<detailed_description>Target variable : - Treatment response - Event Free Survival - Leukemia Free Survival - Graft Versus Host Disease - Regimen relate toxicity</detailed_description>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Aged 021 year Patients suffer either refractory de novo AML relapse AML patient high risk AML CR1 In sexually active patient two reliable contraception method use . This include every combination hormonal contraceptive ( injection , transdermal patch , implant , cervical ring ) intrauterine device ( IUD ) barrier method ( e.g . diaphragm , cervical cap , condom ) spermicide . Written informed consent patient , parent legal guardian Severe renal impairment ( GFR &lt; 30 % predicted age ) Pregnant lactate female Current participation another clinical trial Patients â‰¥ 12 year old Group 1 ( `` BuCyMel '' ) ( patient younger 12 year continue include )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>relapsed refractory AML</keyword>
	<keyword>child , adolescent young adult</keyword>
</DOC>